Aethlon Medical (AEMD) Misses Q1 EPS by 3c

Aethlon Medical (NASDAQ: AEMD) reported Q1 EPS of ($0.16), $0.03 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $132 thousand versus the consensus estimate of $200 thousand.

For earnings history and earnings-related data on Aethlon Medical (AEMD) click here.

You May Also Be Interested In

• Goldman Regional Director in US Adjusts List of Top Names
• Corona-maker Constellation Brands beats estimates, shares jump 2%
• Realty Income (O) Reiterated at Neutral by Cantor Fitzgerald as New JV Announced